OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Capital Raises

Past Charts

Capital Raises

Capital Raises Summary

Each week, Viridian publishes insights and analysis on completed capital raise transactions in the prior week, focusing on all equity and debt deals. Our analysis includes:

  • Summary
  • Outlook
  • Best & Worst Perfromers

Quick Links

YTD Analysis

  • YTD capital raises totaled $690M, down 12.4% from the same period in 2023. Debt as a percentage of capital raised dropped sharply to 27.4% from 62.2% in the previous year on a worldwide basis. The U.S. bucked this trend with 58.8% of capital raised in debt compared to 49.3% in 2023
  • U.S. raises accounted for 46.2% of total funds, the lowest percentage since 2019. Conversely, raises from outside the U.S. represented a historically high 11.2% of the total funds raised.
  • YTD raises by public companies accounted for 61% of total funds.

Market Commentary and Outlook

This Week Sector Focus

Capital Raises vs Stock Prices

  • Cannabis equities (as measured by the MSOS ETF) ended up 10.14% for the week. The MSOS was up 25% on Tuesday, April 30, following the news that the DEA would go along with schedule 3, but gave up most of its gains during the rest of the week.

Best and Worst Stock Performers